SEC Form 4 · accession 0001209191-18-013933
Endo International plc · ENDP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Antonio R Pera
Officer — President, Par Pharmaceutical
Period of report
Feb 23, 2018
Accepted (ET)
Feb 27, 2018 · 4:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001593034
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2,F3 | Feb 23, 2018 | F | 194 | $6.78 | D | 24,581 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Twenty-five percent (25%) of Mr. Pera's February 23, 2016 grant of restricted stock units (RSUs) vested on February 23, 2018.
- F2These shares represent stock withheld by Endo International plc to satisfy Mr. Pera's tax withholding obligations on shares acquired upon vesting of RSUs.
- F3Represents the vesting price which is the average of the high and low share price on February 23, 2018.